Cargando…
Antiangiogenic Therapy for Patients with Recurrent and Newly Diagnosed Malignant Gliomas
Malignant gliomas have a poor prognosis despite advances in diagnosis and therapy. Although postoperative temozolomide and radiotherapy improve overall survival in glioblastoma patients, most patients experience a recurrence. The prognosis of recurrent malignant gliomas is dismal, and more effective...
Autores principales: | Shirai, Katsuyuki, Siedow, Michael R., Chakravarti, Arnab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139866/ https://www.ncbi.nlm.nih.gov/pubmed/21804824 http://dx.doi.org/10.1155/2012/193436 |
Ejemplares similares
-
Progress on Antiangiogenic Therapy for Patients with Malignant Glioma
por: Ahluwalia, Manmeet S., et al.
Publicado: (2010) -
Overcoming Radiation Resistance in Gliomas by Targeting Metabolism and DNA Repair Pathways
por: Meng, Wei, et al.
Publicado: (2022) -
Antiangiogenic Therapy and Mechanisms of Tumor Resistance in Malignant Glioma
por: Rahman, Ruman, et al.
Publicado: (2010) -
Antiangiogenic Therapy for Glioma
por: Cea, Valentina, et al.
Publicado: (2012) -
Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: Analysis of single-agent and combined modality approaches
por: Beal, Kathryn, et al.
Publicado: (2011)